JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
Takayuki Yoshino, G. Pentheroudakis, Saori Mishima, Michael J. Overman, Kun‐Huei Yeh, Eishi Baba, Yoichi Naito, Felipe A. Calvo, Ajit Kumar Saxena, L.-T. Chen, Masayuki Takeda, Andrés Cervantes, Hiroya Taniguchi, Kazuhiro Yoshida, Yasuhiro Kodera, Yuko Kitagawa, Josep Tabernero, Howard A. Burris, J.-Y. Douillard
Topics & Concepts
MedicinePembrolizumabMicrosatellite instabilityOncologyClinical trialCompanion diagnosticInternal medicineClinical OncologyCancerTrk receptorImmunotherapyReceptorNeurotrophinGeneMicrosatelliteAlleleBiochemistryChemistryGenetic factors in colorectal cancerLung Cancer Treatments and MutationsCancer Genomics and Diagnostics